Skip to content
Search

Latest Stories

Pharmacy ownership trends shift in Northern Ireland due to funding gap

W G Hamilton Pharmacy in North Belfast has been sold to first-time buyers as its owner pursues a partial retirement.

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.


Christie & Co confirmed the sale on Tuesday (15 April), marking the third pharmacy in Northern Ireland recently sold to first-time buyers.

The pharmacy, which dispenses an average of 8,750 prescription items per month and collects scripts from over 20 surgeries in the Belfast area, also delivers key NHS services such as the Minor Ailments Service and Pharmacy First.

Owned and operated by Fergus Hamilton for over 20 years, the pharmacy was sold following his decision to pursue a partial retirement.

The sale was managed confidentially by Karl Clezy, director – pharmacy at Christie & Co., and first-time buyers Andrew Crawford and Daniel Cheah have now taken over the reins.

According to Clezy, this is the second pharmacy we have sold in the Ballysillan area over the last few years.

“There have been lots of enquiries on this business since we put it to market, and I am delighted to have sold it to another first-time buyer who I’m sure will take it to further success,” he said.

Clezy noted that the last three pharmacies they have sold in Northern Ireland have been to first-time buyers, which is largely due to “a lack of government funding causing a lot of existing contractors and groups off buying any more pharmacies.”

“This is providing more opportunities for younger buyers to get their first step on the ladder,” he said.

“Whereas before first-time buyers found it difficult to buy their first pharmacy as they were competing with experienced operators who could afford to offer a higher amount.”

Hamilton, former owner of W G Hamilton Pharmacy, wished the new owners “success and prosperity in their new business venture.”

Crawford and Cheah, the new owners, expressed their delight in taking over a long-established and well-run community pharmacy.

“We intend to pick up where Fergus has left off by continuing to provide a first-class service to our patients of north Belfast,” they said, wishing Hamilton “a very happy retirement!”

The pharmacy was sold for an undisclosed sum.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less